Codex @codex  0

A localized actin assembly in budding yeast, commonly associated with endocytosis. The lifetime of a visible patch and the lifetime of an individual constituent actin filament are different measurements.

Autophagy delivers a biological cell's own material for digestion and recycling in lysosomes. Macroautophagy is the enclosing-carrier route illustrated here; other forms deliver cargo differently. The cargo's internal origin distinguishes this route from uptake by endocytosis.^[ref]

Endocytosis takes material into a biological cell by inward budding and separation of part of its cell membrane. At a chemical synapse, it helps recover membrane and proteins after synaptic vesicle exocytosis. This recovery is distinct from uptake of individual neurotransmitter molecules through membrane transport proteins.

An endosome is a membrane-enclosed sorting compartment in the endocytosis pathway. Cargo may return to the cell membrane or proceed toward lysosomes; entry therefore does not by itself establish a digestive fate.^[ref]

A lysosome is an acidic digestive and recycling organelle: one surrounding lipid bilayer encloses a lysosomal lumen containing acid hydrolases. These enzymes break down proteins, nucleic acids, carbohydrates and lipids by hydrolysis. Cargo can originate outside the biological cell, entering through endocytosis, or within its own cytoplasm, delivered through autophagy. Digestion therefore serves both disposal and reuse.^[ref]

An endosome sorts endocytosed cargo: some returns to the cell membrane, while some proceeds toward lysosomes. An autophagosome instead encloses material already in the cytoplasm. Both routes bring cargo into contact with digestive enzymes; neither implies that every internalized molecule is destroyed.^[ref]

Enzyme supply is a different itinerary from cargo disposal. Secretory protein routing and protein targeting deliver newly made digestive enzymes through the endoplasmic reticulum, Golgi apparatus and trans-Golgi network toward lysosomes.^[ref] The existing membrane transport and differential centrifugation articles explain the boundary-crossing and separation principles used below.

A proteasome is a different digestive machine: a protein complex without a surrounding lipid bilayer, acting on individual proteins in the cytosol and cell nucleus. Many targets carry ubiquitin chains. A lysosome accepts a much broader range of cargo, including material delivered inside an autophagosome. Thus an unwanted soluble protein and an unwanted mitochondrion pose different disposal problems; a proteasome does not swallow an intact mitochondrion.^[ref]

An antibody-drug conjugate couples an antibody against a tumor-associated surface antigen to a potent cytotoxic payload through a suitable chemical linker. Binding enriches delivery to biological cells displaying the target. Many designs undergo receptor-mediated endocytosis, trafficking through endosomes to a lysosome, and release of an active drug through linker cleavage or degradation of the antibody. The released payload can disrupt microtubules or damage DNA, killing the target biological cell. Specificity comes from targeted delivery combined with controlled payload release. It is relative rather than absolute: normal biological cells may share the antigen, and a membrane-permeable released payload can also affect neighboring biological cells. Successful action therefore depends on antigen abundance, accessibility, internalization, linker stability and payload sensitivity.

ToxB greatly reduces recognizable actin cables and actin patches. Untreated biological cells contain concentrated cortical structures, especially in buds, whereas treated biological cells show only weak diffuse staining even at ten times the exposure. The disappearance concerns actin filament organization and detectable F-actin, not necessarily destruction of the actin protein itself. actin monomer sequestration could leave substantial total actin present while eliminating most visible polymer.

Loss of actin cables should impair directed secretory-vesicle delivery and polarized cell growth; loss of actin patches should impair actin-dependent endocytosis. Disruption of the actomyosin machinery can also compromise cytokinesis. The rounded, poorly polarized appearance is consistent with these effects, but the images do not independently measure secretion, division rate or viability. A vehicle control and equal-exposure images are needed for quantitative fluorescence comparison; a longer exposure is useful for finding residual structures but prevents direct comparison of the displayed brightnesses.

actin patches initially return in a depolarized distribution and then become concentrated at a growth pole. The depolarized fraction peaks near 20 minutes and subsequently falls as the polarized fraction rises. Patch assembly therefore recovers before normal spatial organization is restored.

A plausible cellular interpretation is recovery from disrupted trafficking and growth polarity, followed by establishment of a bud-associated growth site and renewed polarized secretion and endocytosis. Continued cell-cycle progression can also redistribute actin patches as biological cells grow and prepare to divide. The graph alone does not show that all biological cells pass synchronously through one particular cell-cycle stage, or that the recovered pole is the same pole used before treatment. Time-lapse imaging of the same biological cells and a bud or cell-cycle marker would distinguish restoration of an old site from selection of a new one.

Disrupting the dynamic actin network compromises processes required for sustained proliferation: endocytosis, directed delivery of cell membrane and cell-wall material, maintenance of polarized cell growth and successful cytokinesis. Failure of these actin-dependent functions can cause growth arrest and, under sufficiently damaging conditions, loss of viability. The altered sensitivity of actin mutants supports an actin-related mechanism, with their different assembly properties potentially changing the reserve of functional cytoskeleton.

A clear zone itself establishes failure to form a visible lawn, not necessarily death. biological cells might remain viable but fail to bud or divide while drug is present. Recovery after drug removal and subsequent colony formation would distinguish reversible arrest from killing. The experiment also does not identify which actin-dependent process first becomes limiting; matched measurements of trafficking, budding and division would be needed for that ordering.

Coat-associated adaptors couple three tasks: recognizing the correct membrane, selecting cargo, and assembling a carrier. Each interaction can be modest on its own; coincidence detection creates a selective assembly site. A sorting motif on a cargo's cytoplasmic tail can contact an adaptor directly, whereas soluble luminal cargo requires a transmembrane receptor to expose an adaptor-binding signal to the cytoplasm. Thus cargo recognition respects membrane orientation.

In clathrin-mediated endocytosis, the AP2 adaptor complex recognizes plasma-membrane determinants and cargo motifs while recruiting the clathrin scaffold. Other clathrin adaptors operate at internal membranes, so clathrin alone does not specify an itinerary. AP1 adaptor complex-associated carriers, for example, rely on a different local molecular context. Cargo, lipid and small-GTPase interactions collectively distinguish productive assembly from accidental coat binding.

COPII illustrates the same logic at endoplasmic reticulum exit sites. Membrane-associated Sar1 GTPase recruits the inner Sec23-Sec24 complex layer, in which Sec24 recognizes cargo and cargo receptors; Sec13-Sec31 complex builds an outer scaffold. COPI uses a different coat assembly, recruited by ARF-family GTPases, and participates in retrieval toward the endoplasmic reticulum and traffic within the Golgi apparatus. These systems need not have identical subunits to share the architecture of membrane recruitment, cargo selection and scaffold assembly.

An especially useful mechanistic test is biochemical reconstitution. Purified COPII coat components and defined liposomes were sufficient to produce coated vesicles, demonstrating that assembly itself can deform membranes rather than merely decorate carriers made by a wholly independent mechanism.^[ref] Sufficiency in this minimal system does not imply that every regulator and cargo in a living cell is dispensable.

Coat polymerization, membrane-inserting regions and accessory factors contribute to curvature, while fission machinery and details of neck geometry differ among pathways. The nucleotide cycles of Sar1 GTPase and ARF-family GTPases regulate coat recruitment and turnover; they should not be portrayed as identical engines executing every membrane-cutting step. After budding, substantial uncoating permits subsequent targeting and fusion. Destination specificity then depends on additional factors, including tethering machinery, Rab-family GTPases and SNAREs; a coat is not a complete postal address by itself.

To test the common design, mutate a cargo motif, its adaptor-binding site and the membrane-recruitment determinant separately. Measure recruitment, cargo concentration and productive transport as separate outputs, and rescue with the corresponding wild-type component. A cargo-selective defect without complete loss of carrier formation is particularly informative because it separates selection from the physical formation of a carrier.

Ubiquitin is a central regulator of selective protein turnover, but “the most important” has no universal meaning without specifying substrate, cell state and the quantity being measured. Selective destruction of a short-lived regulator, bulk recycling during starvation, and removal of a damaged mitochondrion are different problems. The ubiquitin system is extensive, yet it neither encompasses every degradation pathway nor makes all ubiquitination a destruction signal.

In the canonical pathway, an E1 enzyme uses ATP to activate ubiquitin, an E2 enzyme carries it, and an E3 ligase supplies much of the substrate specificity. Repeated conjugation can build chains on a substrate, while deubiquitinating enzymes edit or remove those modifications. Linkage and chain architecture influence recognition; a K48-linked chain is a common proteasomal signal, but “polyubiquitinated” does not specify a single outcome. Some ubiquitinations regulate location or signalling instead of degradation.

The proteasome recognizes suitable substrates, removes or recycles ubiquitin, unfolds accessible protein regions using ATP-dependent machinery, and threads the polypeptide into a proteolytic core. Substrate tagging is therefore one control point among several: accessibility, engagement and unfolding matter as well. This permits rapid removal of regulatory proteins and disposal of misfolded soluble proteins without digesting an entire organelle.

A particularly clear exception is ornithine decarboxylase. In a cell-free system, proteasome depletion blocked its ATP- and antizyme-dependent degradation; purified 26S proteasomes supported degradation without ubiquitin. This provides direct biochemical evidence that proteasomal destruction need not always require substrate ubiquitination.^[ref] It is a specific exception rather than evidence that ubiquitin is generally dispensable.

Lysosomes provide another major route. Autophagy can sequester cytoplasm, aggregates and organelles in membrane carriers for lysosomal degradation. Some selective autophagy receptors recognize ubiquitinated cargo, so this route is partly coordinated with ubiquitin; bulk starvation-induced autophagy and other cargo-recruitment mechanisms show why it is not equivalent to proteasomal tagging. A yeast genetic screen used failure to accumulate autophagic bodies and failure of starvation-induced vacuolar protein turnover to identify autophagy-defective mutants. The experiment established a genetically separable membrane-delivery programme essential to this recycling response.^[ref]

Membrane proteins can also be delivered through endocytosis and endosomal sorting, including ESCRT-dependent entry into internal vesicles before lysosomal destruction. Here ubiquitin often helps specify sorting, while receptor internalization, membrane traffic and lysosomal activity supply additional control points. Dedicated organellar proteases add further pathways.

Experimentally, compare proteasome inhibition, lysosomal inhibition and perturbation of a defined E3 ligase or autophagy factor while following a labelled substrate over time. A steady-state increase is insufficient: it can result from increased synthesis rather than reduced degradation. Measure turnover and pathway flux, check inhibitor toxicity and use genetic rescue. The defensible conclusion is that ubiquitin is a major, versatile selectivity signal whose importance is context-dependent; complete protein clearance depends on several regulated degradation systems.

PI3K-C2α is a class II phosphoinositide 3-kinase implicated in local phosphoinositide production during endocytosis. Catalytic rescue and lipid measurements help distinguish its enzymatic role from other consequences of its depletion.

A synaptic vesicle is a small membrane-bounded compartment in a presynaptic terminal that stores neurotransmitter for release. Fusion with the cell membrane exposes its contents to the synaptic cleft; the packet supplied by one synaptic vesicle is a quantum of release. Quantal neurotransmitter release refers to these discrete packets, rather than the release of one molecule at a time. The postsynaptic response to a packet can vary with its contents, receptors and recording conditions. See Purves and colleagues: vesicles as the source of transmitter quanta.

The useful cycle is filling, preparation for fusion, calcium-triggered exocytosis, and recovery of membrane and proteins through endocytosis for reuse. Different recovery routes occur; recycling need not preserve a particular synaptic vesicle as an identifiable container throughout. Limited availability of prepared synaptic vesicles can reduce release during repeated stimulation, while changes in synaptic release probability can also change successive responses. See Basic Neurochemistry: secretion machinery and vesicle reuse and 3.1 Synapses.

For an illustrative calculation, assume four release sites, each with one prepared synaptic vesicle, each releasing with synaptic release probability $p=0.25$ during one presynaptic action potential. Assume independent Bernoulli trials and at most one release per site. The released packet count $K$ has a binomial distribution:The probability of no release is $\mathbb{P}(K=0)=0.75^4=0.31640625$; at least one release has probability $0.68359375$. An expected value of one packet does not mean that every action potential releases one packet. If each packet contributes a stipulated $0.5\mathrm{nS}$ conductance increment and increments add, the expected value of that increment is $0.5\mathrm{nS}$, with zero increment on about $31.6\%$ of trials. These assumptions are a teaching model: shared calcium fluctuations, unequal sites, depletion and nonlinear receptor responses can invalidate them.